CFCarlos Simón Duque Fisher

Carlos Simón Duque Fisher

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Carlos Simón Duque Fisher has a total of 92 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Thyroid Cancer Staging: Historical Evolution and Analysis From Macrocarcinoma to Microcarcinoma

    by Carlos S. Duque, Carlos E Builes-Montaño, Catalina Tobón-Ospina, Alejandro Velez Hoyos, Juan G. Sánchez, Andres F. Londoño, Miguel Agudelo, Julio A Valencia, Juan P. Dueñas, Maria F. Palacio, et al.

    The classification of thyroid cancer diagnosis and treatment has evolved dramatically since the Union for International Cancer Control (UICC) published the first staging system in 1968. A careful review of the eight published editions of well-differentiated thyroid cancer (WDTC) staging by the UICC and the American Joint Committee on Cancer (AJCC) was performed. Each edition was analyzed to clearly understand which development published and accepted by specialists treating thyroid cancer justified considering a new updated edition. This study presents a comprehensive review of the remarkable evolution of thyroid cancer staging, highlighting the various changes in several areas throughout the years and editions. There were surprising changes within the eight publications: the tumor size was progressively reduced from 4 cm in the first AJCC volume to less than 1 cm in the seventh and eighth UICC and AJCC editions, classifying these small, WDTCs known up to now as “microcarcinomas.” Extrathyroidal extension was accepted after the third edition; this description certainly plays a key role in today’s decisions to manage this tumor as a prognostic factor. The age specification of 45 years prevailed for seven consecutive publications until it was raised to 55 years in the eighth thyroid cancer staging system. Without a doubt, this iconic change allowed physicians around the world to give their 45-year-old thyroid cancer patients a more encouraging panorama of the disease with the new classification. Over the course of nearly 57 years, thyroid cancer staging has undergone remarkable changes, reaching a level of certainty that not only provides recommendations for safer treatments with less surgery and adjunctive measures but also improves survival rates and patient safety.


  • The Influence of Impedance on the Efficacy of Radiofrequency Ablation for Benign Thyroid Nodules

    by Juan Pablo Dueñas, Nathalia Buitrago‐Gómez, José Hugo Arias‐Botero, Gregory Randolph, Marika Russell, Amr Abdelhamid Ahmed, Roberto Valcavi, Carlos Simón Duque, Ralph P. Tufano

    Objective: Radiofrequency ablation (RFA) uses the heat generated by a high‐frequency alternating electric current, and according to Ohm's and Joule's law, the delivered current is inversely proportional to the circuit impedance. The primary objective of this study was to investigate whether tissue impedance during radiofrequency ablation (RFA) for benign thyroid nodules is related to the degree of volume reduction.Methods: This observational study included consecutive patients treated with RFA for benign thyroid nodules from February 2020 to August 2023. Technical effectiveness was defined as a volume reduction percentage (VRP) >75% at 6 months after the treatment. Multivariate logistic regression analyses were performed to identify the potential role of clinical factors and changes in tissue impedance on technique effectiveness.Results: Totally 72 patients were included with 73 benign thyroid nodules. Maximal impedance peaks reached 75% at bivariate analysis. These cutoff points were exploratory, as no existing literature suggests these variables are related to the degree of volume reduction. After adjusting for age, volume, and composition, significant associations were found for mean electrical impedance in the multivariate analysis (OR = 4.86 [confidence interval [CI] 1.29–18.26], p = 0.019). The energy adjusted by volume (delivered energy) was not associated with a VRP >75% (p = 0.7746).Conclusions: This study suggests that a mean procedural impedance </= 300 Ω is related to the effectiveness of RFA as measured by VRP. Additional prospective and randomized studies are needed to compare electrical parameters with VRP.Level of Evidence: 3 Laryngoscope, 134:5231–5238, 2024


  • Open Access

    Facial nerve monitoring in parotid gland surgery: Design and feasibility assessment of a potential standardized technique

    by Carlos S. Duque, Andrés F. Londoño, Ana M. Duque, Jhon J. Zuleta, Marcela Marulanda, Lina M. Otálvaro, Miguel Agudelo, Juan P. Dueñas, María F. Palacio, Gianlorenzo Dionigi

    Background: Even though the use of nerve monitoring during parotid gland surgery is not the gold standard to prevent damage to the nerve, it surely offers some advantages over the traditional approach. Different from thyroid surgery, where a series of steps in intraoperative nerve monitoring have been described to confirm not only the integrity but—most importantly—the function of the recurrent laryngeal nerve, in parotid gland surgery, a formal guideline to follow while dissecting the facial nerve has yet to be described.Methods: A five‐year retrospective study was done reviewing the intraoperative records of patients who underwent parotid gland surgery under neural monitoring. The operative findings regarding the neuromonitoring process, particularly in regard to the amplitude of two main branches, were revised. A literature search was done to search for guidelines to follow when a facial nerve loss of signal is encountered.Results: Fifty‐five patients were operated on using the Nim 3 Nerve Monitoring System (Medtronic); 31 were female patients, and 47 patients had benign lesions. Minimum changes were observed in the amplitude records after a comparison was made between the first and the last stimulation. There were only three articles discussing the term loss of signal during parotid gland surgery.Conclusion: Today, no sufficient attention has been given to the facial nerve monitoring process during parotidectomy. This study proposes a formal guideline to follow during this procedure as well as an instruction to consider when a loss of signal is observed to develop a uniform technique of facial nerve stimulation


  • Open Access

    Lesiones metastásicas a glándula tiroides. Una serie de casos

    by Alejandro Vélez-Hoyos, Valentina Agredo-Delgado, Aníbal Ariza-Gutiérrez, Carlos Simón Duque-Fisher, Juan Pablo Dueñas-Muñoz, Catalina Tobón-Ospina, Alejandro Román-González

    Las lesiones metastásicas representan hasta un 3 % de los tumores malignos de la glándula tiroides. La mayoría de los casos se originan de tumores de células renales y de pulmón. El abordaje diagnóstico implica una alta sospecha clínica en pacientes con primarios conocidos, sin embargo, puede ser la manifestación inicial de una enfermedad maligna extensa no diagnosticada hasta en un 20 % a 40 % de los pacientes. La biopsia por aguja fina ha demostrado buen rendimiento para el diagnóstico de los nódulos metastásicos. El pronóstico y la opción del tratamiento quirúrgico dependen del control local del primario y del estado de la enfermedad sistémica asociada, por lo tanto, debe ser individualizado. Por lo general, hasta un 80 % de los pacientes con compromiso de la tiroides tienen enfermedad metastásica multiorgánica, y la intención del tratamiento quirúrgico es con fines paliativos para prevenir las complicaciones derivadas de la extensión local de la enfermedad a las estructuras del tracto aerodigestivo superior en el cuello. Se presenta a continuación, una serie de seis casos de pacientes con lesiones metastásicas a glándula tiroides con primarios en riñón, mama y de melanomas.

  • Open Access

    Facial nerve monitoring in parotid gland surgery: Design and feasibility assessment of a potential standardized technique

    by Carlos S Duque, Andres F Londoño, Ana M Duque, John J Zuleta, Marcela Marulanda, Lina M Otalvaro, Miguel Agudelo, Juan P Dueñas, Maria F Palacio, Gianlorenzo Dionigi

    Introduction Even though the use of nerve monitoring during parotid gland surgery is not the gold standard to prevent damage to the nerve, it surely offers some advantages over the traditional approach. Different from thyroid surgery, where a series of steps in intraoperative nerve monitoring have been described in order to confirm not only the integrity but – most importantly – the function of the recurrent laryngeal nerve, in parotid gland surgery, a formal guideline to follow while dissecting the facial nerve has yet to be described.Methods A five-year retrospective study was done reviewing the intraoperative records of patients who underwent parotid gland surgery under neural monitoring. The operative findings regarding the neuromonitoring process, particularly in regard to the amplitude of two main branches, were revised. A literature search was done in order to search for guidelines to follow when a facial nerve loss of signal is encountered.ResultsFifty-six patients were operated on using the Nim 3 Nerve Monitoring System (Medtronic, Jacksonville, FL USA); thirty-three were female patients, 46 patients had benign lesions. Minimum changes were observed in the amplitude records after a comparison was made between the first and the last stimulation. There were only three articles discussing the term loss of signal during parotid gland surgery.ConclusionToday, no sufficient attention has been given to facial nerve monitoring process during parotidectomy. This study proposes and discusses a formal guideline to follow during this procedure in order to develop a uniform technique of facial nerve stimulation.


  • Open Access

    Horner Syndrome on a female patient, after the removal of a rare location of a cervical Schawannoma. Case description and a short revision

    by Carlos S. Duque, Alejandro Uribe, Nataly Vanegas, Martin Ochoa, Marcela Marulanda, María Fernanda Palacio

  • Open Access

    Masa parotídea de rápido crecimiento, representando un dilema diagnóstico

    by Carlos Simón Duque Fisher, Erika Marcela Sánchez, Alfredo Martelo, Alicia Hidron, Miguel Agudelo

    Toxoplasmosis is a parasitic infection with worldwide distribution, whose definitive host is felines. It is only symptomatic in less than 20% of immunocompetent patients. Symptoms may vary from general malaise, fever, weakness and the presence of cervical lymphadenopathy. A description of an uncommon presentation of this disease in a male patient with progressively growing left-sided parotid mass, in whom a parotidectomy was performed to rule out lymphoproliferative disease. Infection by Toxoplasma gondii was diagnosed after a series of exams.

  • Open Access

    Neurofibroma del asa del hipogloso: reporte de caso

    by Carlos Simón Duque-Fisher, Erika Marcela Sanchez, Miguel Agudelo

    Neurofibromas are benign tumors that originate from the sheet of peripheral nerves, even though rare, they are occasionally seen in patients with a prior history of neurofibromatosis type1, in which case a sporadic form is diagnosed. A 27-year-old male is described with a left asymptomatic supraclavicular slow growing mass. During surgery it was found that the tumor was originating from the Ansa Hypoglossi